How do we handle the anti-HBc positive patient? (in highly endemic settings).
作者信息
Lau George K K
机构信息
Institute of Translational Hepatology, Military Hospital, Beijing, China; and Humanity and Health Gastroenterology and Liver Clinic Hong Kong.
出版信息
Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):29-31. doi: 10.1002/cld.399. eCollection 2015 Feb.
Abstract
摘要
相似文献
1
How do we handle the anti-HBc positive patient? (in highly endemic settings).我们如何处理抗-HBc阳性患者？（在高流行地区）。
Clin Liver Dis (Hoboken). 2015 Mar 27;5(2):29-31. doi: 10.1002/cld.399. eCollection 2015 Feb.
2
Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.塞舌尔普通人群中乙肝患病率下降，丙肝病毒感染率较低。
Bull World Health Organ. 1999;77(11):923-8.
3
The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country.荷兰是乙肝病毒低流行国家，其乙肝核心抗原供体筛查通用抗体的检出率
Transfusion. 2015 Jun;55(6):1206-13. doi: 10.1111/trf.12962. Epub 2014 Dec 15.
4
Prevention of de novo hepatitis B virus infection in living donor liver transplantation using hepatitis B core antibody positive donors.使用乙肝核心抗体阳性供体预防活体肝移植中乙肝病毒的新发感染
Clin Transplant. 2002 Dec;16(6):405-9. doi: 10.1034/j.1399-0012.2002.01133.x.
5
Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.乙肝病毒流行地区非B非C型肝细胞癌的临床特征及潜在病因
Liver Int. 2016 Sep;36(9):1351-61. doi: 10.1111/liv.13099. Epub 2016 Mar 24.
6
Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.乙肝病毒流行地区HBsAg阴性但抗-HBc阳性的肝细胞癌的临床特征
J Gastroenterol Hepatol. 2005 May;20(5):746-51. doi: 10.1111/j.1440-1746.2005.03747.x.
7
Prevalence of isolated antibody to hepatitis B core antigen in an area endemic for hepatitis B virus infection: implications in hepatitis B vaccination programs.乙型肝炎病毒感染流行地区中单纯乙型肝炎核心抗原抗体的流行情况：对乙型肝炎疫苗接种计划的影响
Hepatology. 1988 Jul-Aug;8(4):766-70. doi: 10.1002/hep.1840080411.
8
HBV and HCV infection in Japanese dental care workers.日本牙科护理人员中的乙肝病毒和丙肝病毒感染
Int J Mol Med. 2008 Jun;21(6):791-9.
9
[Antibodies against hepatitis B virus core antigen among blood donors].献血者中抗乙型肝炎病毒核心抗原抗体
Transfus Clin Biol. 2000 Feb;7(1):63-9. doi: 10.1016/s1246-7820(00)88713-3.
10
Occult hepatitis B virus infection in Korean patients with isolated anti-HBc.韩国孤立抗-HBc 患者中的隐匿性乙型肝炎病毒感染。
Arch Virol. 2014 Feb;159(2):227-33. doi: 10.1007/s00705-013-1810-8. Epub 2013 Aug 10.
引用本文的文献
1
Prevalence of hepatitis B virus infection and associated factors among students living on campus in South-eastern Gabon.加蓬东南部住校学生中乙肝病毒感染的流行情况及相关因素
BMC Infect Dis. 2025 Aug 7;25(1):992. doi: 10.1186/s12879-025-11409-0.
2
Prevalence of hepatitis B virus infection and its associated factors among students in N'Djamena, Chad.乍得恩贾梅纳学生中乙型肝炎病毒感染的流行情况及其相关因素。
PLoS One. 2024 Apr 18;19(4):e0273589. doi: 10.1371/journal.pone.0273589. eCollection 2024.
3
Management of hepatitis B reactivation in immunosuppressed patients: An update on current recommendations.免疫抑制患者中乙肝再激活的管理：当前推荐的最新进展。
World J Hepatol. 2016 Mar 18;8(8):385-94. doi: 10.4254/wjh.v8.i8.385.
本文引用的文献
1
Lack of hepatitis B virus reactivation after anti-tumour necrosis factor treatment in potential occult carriers with chronic inflammatory arthropathies.潜在隐匿性乙型肝炎病毒携带者慢性炎症性关节炎应用肿瘤坏死因子拮抗剂治疗后病毒无再激活。
Eur J Intern Med. 2014 Jun;25(5):482-4. doi: 10.1016/j.ejim.2013.11.014. Epub 2014 Feb 2.
2
Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study.化疗引起的已治愈乙型肝炎病毒感染淋巴瘤患者的肝炎再激活：一项前瞻性研究。
Hepatology. 2014 Jun;59(6):2092-100. doi: 10.1002/hep.26718. Epub 2014 Apr 14.
3
Reprint of: Epidemiological serosurvey of Hepatitis B in China--declining HBV prevalence due to Hepatitis B vaccination.乙型肝炎在中国的血清流行病学调查——乙型肝炎疫苗接种导致乙型肝炎病毒流行率下降。
Vaccine. 2013 Dec 27;31 Suppl 9:J21-8. doi: 10.1016/j.vaccine.2013.08.012. Epub 2013 Aug 12.
4
Long-term efficacy of nucleoside monotherapy in preventing HBV infection in HBsAg-negative recipients of anti-HBc-positive donor livers.核苷单药疗法预防抗-HBc 阳性供肝受者 HBsAg 阴性的 HBV 感染的长期疗效。
Hepatol Int. 2010 Jul 29;4(4):707-15. doi: 10.1007/s12072-010-9188-0.
5
Liver grafts from anti-hepatitis B core positive donors: a systematic review.来自抗乙肝核心阳性供体的肝移植物：系统评价。
J Hepatol. 2010 Feb;52(2):272-9. doi: 10.1016/j.jhep.2009.11.009. Epub 2010 Jan 19.
6
Hepatitis B reactivation after chemotherapy: two decades of clinical research.乙型肝炎化疗后再激活：二十年来的临床研究。
Hepatol Int. 2008 Jun;2(2):152-62. doi: 10.1007/s12072-008-9056-3. Epub 2008 Mar 5.
7
Hepatitis B virus infection and transfusion medicine: science and the occult.乙型肝炎病毒感染与输血医学：科学与隐匿因素
Transfusion. 2008 May;48(5):1001-26. doi: 10.1111/j.1537-2995.2008.01701.x.
8
Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.接受细胞毒性化疗的HBsAg阴性患者中乙型肝炎病毒新发感染的动力学及风险
Gastroenterology. 2006 Jul;131(1):59-68. doi: 10.1053/j.gastro.2006.04.015.
9
New insight on hepatitis B virus persistence from the study of intrahepatic viral cccDNA.从肝内病毒cccDNA研究中获得的关于乙型肝炎病毒持续感染的新见解。
J Hepatol. 2005 Mar;42(3):302-8. doi: 10.1016/j.jhep.2004.12.015.
10
Antibody to hepatitis-B-virus core in man.人类抗乙型肝炎病毒核心抗体
Lancet. 1973 Oct 20;2(7834):869-73. doi: 10.1016/s0140-6736(73)92004-7.
Zotero 插件